Universal DX

Universal DX is a U.S.-based company developing blood tests to detect cancer in its earliest stages. Their approach uses multi-omics, computational biology, and machine learning to capture cancer's signal in the blood. Their first test, Signal-C®, can accurately detect colorectal cancer with high sensitivity and specificity. The company is collaborating with Quest Diagnostics to accelerate the impact of their technology in the fight against cancer.